Kaplan–Meier survival analysis revealed that ICC patients with high levels of p62 had a significantly shorter overall survival and higher cumulative recurrence rate compared with those with low expression of p62 (p = 0.0082 and p = 0.0034, respectively) (Figure 1E,F). Here, SQSTM1 is linked to intrahepatic cholangiocarcinoma.